申请人:Daugan Alain Claude-Marie
公开号:US20100041696A1
公开(公告)日:2010-02-18
The present invention relates to substituted 4-Aminopyrazole compounds of the formula (I):
and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
本发明涉及式(I)的替代4-氨基吡唑化合物及其药学上可接受的盐,含有它们的制药组合物及其在医学上的用途。特别是,本发明涉及用于调节SCD活性的化合物。